Scalper1 News
Two hot medical stocks report fourth-quarter earnings on Tuesday. Regeneron (REGN), which develops drugs to treat eye diseases and cancer, reports before the open. Its earnings growth is projected to triple. Shares have risen 35% over the last 12 months. Medical record software maker Cerner (CERN) reports after the close. Earnings growth is expected to accelerate for a third straight quarter. Its stock has gained 21% over the last 12 months. Scalper1 News
Scalper1 News